Pancreatic Cancer Research

ResearcherOsaka International Cancer InstituteNo recent work listed

Kazuhiro Katayama

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6987-1176; OpenAlex author ID A5101744609. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
20
Papers, trials and grants by year

2018: 3 papers · 2019: none · 2020: 4 papers · 2021: 2 papers

Papers 9

  1. Efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with S-1 as second-line chemotherapy in metastat… Co-author DOI 10.1002/jgh3.12555↗
  2. Predictive Factors for Pancreatic Cancer and Its Early Detection Using Special Pancreatic Ultrasonography in High-Risk Individuals. Last author DOI 10.3390/cancers13030502↗
  3. Effectiveness of Contrast-Enhanced Ultrasonography for the Characterization of Small and Early Stage Pancreatic Adenocarcinoma. Co-author DOI 10.1016/j.ultrasmedbio.2020.04.016↗
  4. Efficacy of Larger-Diameter Plastic Stent Placement for Preoperative Biliary Drainage in Patients Receiving Neoadjuvant Chemoradiation for Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001509↗
  5. Clinical Utility of Pancreatic Cancer Circulating Tumor DNA in Predicting Disease Progression, Prognosis, and Response to Chemotherapy. Last author DOI 10.1097/mpa.0000000000001652↗
  6. Endoscopic ultrasound-guided fiducial marker placement for neoadjuvant chemoradiation therapy for resectable pancreatic cancer. Co-author DOI 10.4251/wjgo.v12.i7.768↗
  7. A case of stage IA pancreatic ductal adenocarcinoma accompanied with focal pancreatitis demonstrated by contrast-enhanced ultrasonography. Co-author DOI 10.1007/s10396-018-0870-5↗
  8. Clinical Features and Prognosis of Patients With the Bone Metastasis of Pancreatic Cancer: A Single-Institutional Cohort Study. Co-author DOI 10.1097/mpa.0000000000001098↗
  9. The Role of Transabdominal Ultrasound in the Diagnosis of Early Stage Pancreatic Cancer: Review and Single-Center Experience. Last author DOI 10.3390/diagnostics9010002↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kazuyoshi Ohkawa · 8 shared papers, 2018–2021 · strength 0.79
  2. Reiko Ashida · 7 shared papers, 2018–2021 · strength 0.72
  3. Kenji Ikezawa · 6 shared papers, 2018–2021 · strength 0.61
  4. Ryoji Takada · 6 shared papers, 2018–2021 · strength 0.60
  5. Nobuyasu Fukutake · 5 shared papers, 2020–2021 · strength 0.53
  6. Tatsuya Ioka · 5 shared papers, 2018–2021 · strength 0.48
  7. Hidenori Takahashi · 4 shared papers, 2018–2021 · strength 0.39
  8. Junko Fukuda · 4 shared papers, 2018–2021 · strength 0.37
  9. Sachiko Tanaka · 4 shared papers, 2018–2021 · strength 0.37
  10. Takuo Yamai · 3 shared papers, 2020–2021 · strength 0.32
  11. Shigenori Nagata · 3 shared papers, 2018–2021 · strength 0.29
  12. Hirofumi Akita · 2 shared papers, 2018–2020 · strength 0.18
  13. Teruki Teshima · 1 shared paper, 2020 · strength 0.11
  14. Shingo Ohira · 1 shared paper, 2020 · strength 0.11
  15. Kazuma Daiku · 1 shared paper, 2021 · strength 0.11
  16. Yugo Kai · 1 shared paper, 2021 · strength 0.11
  17. Kikuya Kato · 1 shared paper, 2020 · strength 0.10
  18. Yoji Kukita · 1 shared paper, 2020 · strength 0.10
  19. Norifumi Naka · 1 shared paper, 2018 · strength 0.07
  20. Hidetatsu Outani · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.